USANA Q4 results
This article was originally published in The Tan Sheet
Executive Summary
USANA Health Sciences announces Jan. 10 it expects net sales for its fourth quarter ended Dec. 30, 2006 to be approximately $101 mil. before it reclassifies its financial report. The Salt Lake City-based firm says it will make an "immaterial reclassification to its consolidated financial statements beginning with the fourth quarter of 2006." USANA says the reclassification will reduce net sales by approximately 1.5%. The firm also says it anticipates net sales for full-year 2006 to be approximately $374 mil. The company also says it commenced operations in Malaysia on Jan. 8...
You may also be interested in...
USANA files lawsuit
USANA Health Sciences announces March 15 it has filed a lawsuit against the Fraud Discovery Institute and Barry Minkow in the U.S. District Court in Salt Lake City, Utah for defamation. In a March 15, 2007 Wall Street Journal article Minkow said he bought "put" options on USANA's shares in a bet the price will fall. The Salt Lake City-based firm says in a release it believes "this is a campaign to manipulate USANA's stock price that is being orchestrated by an individual who served 7 years in prison for stock fraud." The company says Minkow's assertions about USANA's sales model are "false and misleading." In January the firm said it expected net sales for its fourth quarter to be approximately $101 mil. before it reclassified its financial report (1"The Tan Sheet," Jan. 15, 2007, In Brief)...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.